Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 5/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26344420 | 0.98 | GRM5 (0.38) | GRM5PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL26344580 | 0.91 | GRM5 (0.39) | GRM5PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL26344418 | 0.90 | PDE10A (0.38) | PDE10AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL26344602 | 0.90 | GRM5 (0.39) | GRM5PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL26344449 | 0.90 | PDE10A (0.39) | GRM5PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL26344409 | 0.89 | MAPK1 (0.46) | GRM5ALDH1A1HTTHSD17B10 | |
| SCHEMBL26344397 | 0.89 | KMT2A (0.40) | PDE10AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL26344470 | 0.88 | PDE10A (0.38) | GRM5PDE10AKDM4EALDH1A1HPGD | |
| SCHEMBL26344412 | 0.88 | KMT2A (0.40) | PDE10AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL26343557 | 0.88 | MEN1 (0.43) | PDE10AKDM4EALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, OR10J3, TMEM109 | GRM5 1769/4885PDE10A 4018/4885KDM4E 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.